- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06329687
A Study Evaluating the Safety of the Nasal Pump
April 17, 2024 updated by: Oyster Point Pharma, Inc.
A Phase 4, Single-Center, Open-Label Study Evaluating the Safety of the Tyrvaya Nasal Pump
The objective of this study is to determine the safety of the Tyrvaya nasal pump.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The study is testing the hypothesis that the use of the Tyrvaya nasal pump with silicone lubricant does not introduce any additional safety concerns as compared to the safety of the Tyrvaya nasal pump without the additional silicone lubricant.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Newport Beach, California, United States, 92663
- United States, California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Be at least 18 years of age
- Have provided verbal and written informed consent
- Willing to comply with all study related visits and procedures
Exclusion Criteria:
- Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to Visit 1.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nasal Pump
Tyrvaya nasal pump with additional silicone lubricant
|
Tyrvaya Nasal Pump with Silicone Lubricant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Adverse Events
Time Frame: 7 days
|
Adverse Events with the nasal pump with additional silicone lubricant
|
7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tear Film Break up Time
Time Frame: 7 days
|
Change from baseline in Tear Film Breakup Time.
A lower time value indicates a worse outcome.
|
7 days
|
Eye Dryness Score
Time Frame: 7 days
|
Change from baseline in Eye Dryness Scores.
EDS is collected on VAS from 0-100 with a lower score indicating a better outcome.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2024
Primary Completion (Actual)
February 28, 2024
Study Completion (Actual)
February 28, 2024
Study Registration Dates
First Submitted
March 19, 2024
First Submitted That Met QC Criteria
March 19, 2024
First Posted (Actual)
March 26, 2024
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 17, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OPP-010
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Senju Pharmaceutical Co., Ltd.CompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Singapore National Eye CentreCompleted
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
Singapore National Eye CentreCompleted
Clinical Trials on Tyrvaya Nasal Pump
-
Massachusetts General HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...UnknownHypogonadotropic Hypogonadism | Amenorrhea | Kallmann's SyndromeUnited States
-
University of California, San FranciscoOregon Health and Science UniversityCompletedBrain Death | Organ Donation | Delayed Graft Function | Organ Transplant Failure or RejectionUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownTransient Tachypnea of NewbornTurkey
-
Imperial College LondonNovartis PharmaceuticalsCompleted
-
St. Petersburg State Pavlov Medical UniversityRecruitingIschemic Heart Disease | Coronary Artery Bypass GraftingRussian Federation
-
The University of Texas Health Science Center,...TerminatedHeart Failure | LVADUnited States
-
University Hospital OstravaUniversity of OstravaRecruitingNasal Obstruction | Pituitary Adenoma InvasiveCzechia
-
GlaxoSmithKlineCompletedSleep Disorders | Congestion, NasalUnited States
-
Aardvark Medical CompanyCompletedSinusitis | Allergic Rhinitis | Nasal Congestion | Respiratory Tract InfectionUnited States
-
Eisai Inc.TerminatedMyelodysplastic SyndromesUnited States